CA
CLBT icon

Cliff Asness’s Cellebrite CLBT Stock Holding History

Cliff Asness’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Sell
13,712
-20,390
-60% -$269K ﹤0.01% 3802
2026
Q1 		$470K Buy
+34,102
New +$514K ﹤0.01% 3154
2025
Q1 		– Sell
-735,566
Closed -$16.2M – 3159
2024
Q4 		$16.2M Buy
+735,566
New +$14.2M 0.02% 706

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Cliff Asness's CLBT Position: Q2 2026 in Review

Cliff Asness reduced its Cellebrite (CLBT) stake by 60% in Q2 2026, selling an estimated $269K and leaving 13,712 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #3802.

Cliff Asness first reported a position in CLBT in Q4 2024 and has held it in 3 quarters since. The position peaked at $16.2M in Q4 2024. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Cliff Asness held 13,712 shares of Cellebrite worth $200K as of Q2 2026.
  • Cliff Asness sold 20,390 Cellebrite shares in Q2 2026, an estimated $269K.
  • Cellebrite made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3802 holding.
  • Cliff Asness first reported a position in Cellebrite in Q4 2024 and has held it in 3 quarters since.
  • Cliff Asness's Cellebrite position peaked at $16.2M in Q4 2024.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.